ENDRA Life Sciences Inc. (NDRA) — 分析师展望 / 分析师共识目标价为. 基于 4 位分析师评级, 共识为 看涨 — 4 买入.
分析师预估 每股收益(EPS)为 $-47.46 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-56.94 vs 预期 $-47.46 (不及预期 -20%). 2025: 实际 $-8.93 vs 预期 $-6.59 (不及预期 -35.5%). 分析师准确度: 79%.
NDRA 分析师评级
Buy
基于过去3个月内 4 位分析师对 ENDRA Life Sciences Inc. 的评级
EPS 预测 — NDRA
79%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$56.94
vs Est –$47.46
▼ 16.6% off
2025
Actual –$8.93
vs Est –$6.59
▼ 26.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — NDRA
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
